A plethora of genetic (MUC5, HLA genes), environmental (smoking), demographic (older age, male sex), clinical (high titers of ACPA and RF) and drug-related risk factors were reported to contribute to the increased risk of developing ILD in the context of RA (79, 80). The gene discussed is PRTN3; the disease is rheumatoid arthritis.